CMS Names the Next 15 Meds Due for ‘Negotiation’
And HHS is working to identify and limit legal risks around TrumpRx and other pharm-to-table programs
Jan 28, 2026
And HHS is working to identify and limit legal risks around TrumpRx and other pharm-to-table programs
Jan 28, 2026
Everything drug pricing and policy, every day.